Production of transgenic mice expressing tumor virus A under ovarian‑specific promoter 1 control using testis‑mediated gene transfer

Chen,Xinhua; Zhang,Zujuan; Chang,Xiaohong; Niu,Yidong; Cui,Heng

doi:10.3892/mmr.2013.1876

Production of transgenic mice expressing tumor virus A under ovarian‑specific promoter 1 control using testis‑mediated gene transfer

Authors:
- Xinhua Chen
- Zujuan Zhang
- Xiaohong Chang
- Yidong Niu
- Heng Cui
View Affiliations

Affiliations: Gynecologic Oncology Center, Peking University People's Hospital, Beijing 100044, P.R. China, Laboratory Animal Center, Peking University People's Hospital, Beijing 100044, P.R. China
Published online on: December 20, 2013 https://doi.org/10.3892/mmr.2013.1876
Pages: 955-960

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to produce transgenic mice expressing tumor virus A (TVA) in the ovary under ovarian specific promoter 1 (OSP1) control. A transgenic mouse model was established in which TVA, an avian retroviral receptor gene driven by OSP1, was selectively expressed in the ovary. A recombinant plasmid containing TVA cDNA and an OSP1 promoter was constructed. The DNA fragment was repeatedly injected into male mouse testes at multiple sites. At 4‑7, 7‑10 and 10‑13 weeks following the final injection, two DNA‑injected male mice were mated with four wild‑type female mice to produce transgenic mice. The transgenic positive rate in mouse F1 offspring was 39.69%. When the positive F1 individuals were mated with wild‑type Imprinting Control Region mice (PxW) or with positive F1 individuals (PxP), the F2 individuals had a transgenic rate of 12.44%. The transgenic rates in the F1 offspring, produced following mating at the three time intervals, were 55.71 (39/70), 30.77 (4/13) and 18.75% (9/48), respectively. The transgenic rates of the F2 offspring decreased with the age of the F1 offspring, from 26.67% when PxP were mated at 6‑8 weeks of age to 6.52% when PxW were mated at 5‑6 months of age. The results indicate a high efficiency of gene transfer to F1 offspring using testis‑mediated gene transfer (TMGT). The transgenic rate in the F2 offspring was lower than that in the F1 offspring. The results reveal that TMGT is suitable for creating transgenic animals among F1 offspring. Semi‑quantitative reverse transcription-polymerase chain reaction results showed that TVA was expressed in the mice ovaries. The results demonstrate the importance of using the replication‑competent avian sarcoma‑leukosis virus long terminal repeat with a splice acceptor‑TVA system in ovarian tumorigenesis research.

View Figures

View References

1	Gordon JW, Scangos GA, Plotkin DJ, Barbosa JA and Ruddle FH: Genetic transformation of mouse embryos by microinjection of purified DNA. Proc Natl Acad Sci USA. 77:7380–7384. 1980. View Article : Google Scholar : PubMed/NCBI
2	Chan AW: Transgenic animals: current and alternative strategies. Cloning. 1:25–46. 1999. View Article : Google Scholar : PubMed/NCBI
3	Mullins LJ and Mullins JJ: Transgenesis in the rat and larger mammals. J Clin Invest. 97:1557–1560. 1996. View Article : Google Scholar : PubMed/NCBI
4	Wall RJ: New gene transfer methods. Theriogenology. 57:189–201. 2002. View Article : Google Scholar : PubMed/NCBI
5	Niu Y and Liang S: Progress in gene transfer by germ cells in mammals. J Genet Genomics. 35:701–714. 2008. View Article : Google Scholar : PubMed/NCBI
6	Moreira PN, Pozueta J, Pérez-Crespo M, Valdivieso F, Gutiérrez-Adán A and Montoliu L: Improving the generation of genomic-type transgenic mice by ICSI. Transgenic Res. 16:163–168. 2007. View Article : Google Scholar : PubMed/NCBI
7	Ivics Z, Izsvák Z, Medrano G, Chapman KM and Hamra FK: Sleeping Beauty transposon mutagenesis in rat spermatogonial stem cells. Nat Protoc. 6:1521–1535. 2011. View Article : Google Scholar : PubMed/NCBI
8	Dhup S and Majumdar SS: Transgenesis via permanent integration of genes in repopulating spermatogonial cells in vivo. Nat Methods. 5:601–603. 2008. View Article : Google Scholar : PubMed/NCBI
9	Lois C, Hong EJ, Pease S, Brown EJ and Baltimore D: Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science. 295:868–872. 2002. View Article : Google Scholar : PubMed/NCBI
10	Yang SY, Wang JG, Cui HX, et al: Efficient generation of transgenic mice by direct intraovarian injection of plasmid DNA. Biochem Biophys Res Commun. 358:266–271. 2007. View Article : Google Scholar : PubMed/NCBI
11	Bu W, Chen J, Morrison GD, et al: Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer. Oncogene. 30:4399–4409. 2011. View Article : Google Scholar
12	Du Z and Li Y: RCAS-TVA in the mammary gland: an in vivo oncogene screen and a high fidelity model for breast transformation? Cell Cycle. 6:823–826. 2007. View Article : Google Scholar : PubMed/NCBI
13	Du Z, Podsypanina K, Huang S, et al: Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models. Proc Natl Acad Sci USA. 103:17396–17401. 2006. View Article : Google Scholar : PubMed/NCBI
14	Hambardzumyan D, Amankulor NM, Helmy KY, Becher OJ and Holland EC: Modeling adult gliomas using RCAS/t-va technology. Transl Oncol. 2:89–95. 2009. View Article : Google Scholar : PubMed/NCBI
15	Lewis BC, Klimstra DS and Varmus HE: The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer. Genes Dev. 17:3127–3138. 2003. View Article : Google Scholar : PubMed/NCBI
16	Loftus SK, Larson DM, Watkins-Chow D, Church DM and Pavan WJ: Generation of RCAS vectors useful for functional genomic analyses. DNA Res. 8:221–226. 2001. View Article : Google Scholar : PubMed/NCBI
17	Niu Y and Liang SL: Mammalian models based on RCAS-TVA technique. Zoological Res. 3:335–345. 2008.
18	Reddy JP and Li Y: The RCAS-TVA system for introduction of oncogenes into selected somatic mammary epithelial cells in vivo. J Mammary Gland Biol Neoplasia. 14:405–409. 2009. View Article : Google Scholar : PubMed/NCBI
19	Sausville J, Molinolo AA, Cheng X, et al: RCAS/SCL-TVA animal model allows targeted delivery of polyoma middle T oncogene to vascular endothelial progenitors in vivo and results in hemangioma development. Clin Cancer Res. 14:3948–3955. 2008. View Article : Google Scholar
20	Orsulic S: An RCAS-TVA-based approach to designer mouse models. Mamm Genome. 13:543–547. 2002. View Article : Google Scholar : PubMed/NCBI
21	Xing D and Orsulic S: A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistance. Proc Natl Acad Sci USA. 102:6936–6941. 2005. View Article : Google Scholar
22	Bao R, Selvakumaran M and Hamilton TC: Targeted gene therapy of ovarian cancer using an ovarian-specific promoter. Gynecol Oncol. 84:228–234. 2002. View Article : Google Scholar : PubMed/NCBI
23	Selvakumaran M, Bao R, Crijns AP, Connolly DC, Weinstein JK and Hamilton TC: Ovarian epithelial cell lineage-specific gene expression using the promoter of a retrovirus-like element. Cancer Res. 61:1291–1295. 2001.PubMed/NCBI
24	He X, Qi B, Liu G, Yu W and Chen Q: A novel method to transfer gene in vivo system. Prog Biochem Biophys. 33:685–690. 2006.
25	Chang KT, Ikeda A, Hayashi K, et al: Production of transgenic rats and mice by the testis-mediated gene transfer. J Reprod Dev. 45:29–36. 1999. View Article : Google Scholar
26	Shen W, Li L, Pan Q, Min L, Dong H and Deng J: Efficient and simple production of transgenic mice and rabbits using the new DMSO-sperm mediated exogenous DNA transfer method. Mol Reprod Dev. 73:589–594. 2006. View Article : Google Scholar : PubMed/NCBI
27	Sato M, Ishikawa A and Kimura M: Direct injection of foreign DNA into mouse testis as a possible in vivo gene transfer system via epididymal spermatozoa. Mol Reprod Dev. 61:49–56. 2002. View Article : Google Scholar : PubMed/NCBI
28	Valenzuela M, Relloso M and Esponda P: In vivo transfection of the mouse vas deferens. J Exp Zool. 293:532–540. 2002. View Article : Google Scholar : PubMed/NCBI
29	Celebi C, Auvray P, Benvegnu T, Plusquellec D, Jégou B and Guillaudeux T: Transient transmission of a transgene in mouse offspring following in vivo transfection of male germ cells. Mol Reprod Dev. 62:477–482. 2002. View Article : Google Scholar : PubMed/NCBI
30	Yonezawa T, Furuhata Y, Hirabayashi K, Suzuki M, Takahashi M and Nishihara M: Detection of transgene in progeny at different developmental stages following testis-mediated gene transfer. Mol Reprod Dev. 60:196–201. 2001. View Article : Google Scholar : PubMed/NCBI
31	Coward K, Kubota H, Hibbitt O, McIlhinney J, Kohri K and Parrington J: Expression of a fluorescent recombinant form of sperm protein phospholipase C zeta in mouse epididymal sperm by in vivo gene transfer into the testis. Fertil Steril. 85(Suppl 1): 1281–1289. 2006. View Article : Google Scholar : PubMed/NCBI
32	Hibbitt O, Coward K, Kubota H, et al: In vivo gene transfer by electroporation allows expression of a fluorescent transgene in hamster testis and epididymal sperm and has no adverse effects upon testicular integrity or sperm quality. Biol Reprod. 74:95–101. 2006. View Article : Google Scholar
33	Kubota H, Hayashi Y, Kubota Y, Coward K and Parrington J: Comparison of two methods of in vivo gene transfer by electroporation. Fertil Steril. 83(Suppl 1): 1310–1318. 2005. View Article : Google Scholar : PubMed/NCBI
34	Gilbert SF: Developmental Biology. 8th edition. Sinauer Associates; Sunderland, MA: pp. 613–646. 2006
35	Schlatt S: Spermatogonial stem cell preservation and transplantation. Mol Cell Endocrinol. 187:107–111. 2002. View Article : Google Scholar : PubMed/NCBI
36	Ju H, Bai L, Ren H, Mu Y, Yang S and Li K: Production of transgenic mice by type-A spermatogonia-mediated gene transfer. Agri Sci Chin. 10:431–437. 2011. View Article : Google Scholar